Reply to: Skin moisturization for xerosis related to targeted anticancer therapies

To the Editor: We would like to thank Drs Gisondi and Girolomoni for their comments regarding the treatment of xerosis. We agree that salicylic acid and ammonium lactate should be used judiciously, and only on areas of hyperkeratosis without evident dermatitis, as is commonly seen in patients treate...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2015

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/25970

Acceso en línea:

https://doi.org/10.1016/j.jaad.2015.03.038
https://repository.urosario.edu.co/handle/10336/25970

Palabra clave:

Antineoplastic agent
Antineoplastic agent
Enzyme inhibitor
Monoclonal antibody
Eczema
Human
Hyperkeratosis
Incidence
Keratinocyte
Letter
Moisture
Molecularly targeted therapy
Priority journal
Skin function
Skin moisturization
Xerosis
Adverse effects
Chemically induced
Molecularly targeted therapy
Neoplasms
Skin disease
Antibodies
monoclonal
Antibodies
monoclonal
Antineoplastic agents
Antineoplastic agents
Enzyme inhibitors
Enzyme inhibitors
Humans
Humans
Molecular targeted therapy
Molecular targeted therapy
Neoplasms
Neoplasms
Skin diseases
Skin diseases

Rights

License

Restringido (Acceso a grupos específicos)